Latest News about HALO
Recent news which mentions HALO
Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina
November 14, 2022
From Benzinga
Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday
November 09, 2022
From Benzinga
Argenx Seeks FDA Nod For Its Flagship Neuromuscular Treatment Formulated For Subcutaneous Injection
September 21, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2022
From Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 02, 2022
From Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
7 Biotech Stocks With Key Catalysts Coming in July
June 27, 2022
From InvestorPlace
Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International
May 24, 2022
From Benzinga
MindMed Appoints Schond L. Greenway As CFO
May 23, 2022
From Benzinga
From Benzinga
Why Is Sierra Oncology (SRRA) Stock Up Today?
April 13, 2022
From InvestorPlace
Why Antares Pharma Stock Is Soaring Today
April 13, 2022
From Benzinga
Why Is Antares Pharma (ATRS) Stock Up Today?
April 13, 2022
From InvestorPlace
Benzinga's Daily Brief On Trending Tickers For April 13, 2022: JPMorgan, PayPal, Bed Bath & Beyond And More
April 13, 2022
From Benzinga
Why Antares Pharma Stock Is Bolting Higher Today
April 13, 2022
From Motley Fool
From Benzinga
From Benzinga
Halozyme Buys Antares In $960M Deal To Create One Drug Delivery, Specialty Product Entity
April 13, 2022
From Benzinga
From InvestorPlace
From Benzinga
Is 'Halo' A Hit For Paramount+? Here's The Record It Broke
March 29, 2022
From Benzinga
Halozyme, Chugai Ink $185M ENHANZE Technology Licensing Pact
March 24, 2022
Tickers
HALO
From Benzinga
Argenx's Subcutaneous Efgartigimod At Par With Intravenous Administration In Neuromuscular Disorder
March 22, 2022
From Benzinga
From Benzinga
Halozyme's Q4 Earnings Beat Consensus Despite Lower Product Sales Hit Topline Growth
February 23, 2022
Tickers
HALO
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.